Kezhen Liu has worked in various roles in the biostatistics field throughout their career. Kezhen is currently the Head of Biometrics at Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. since September 2021. Prior to that, they worked as the Director of Biostatistics at CStone Pharmaceuticals from September 2018 to September 2021.
Before joining CStone Pharmaceuticals, Kezhen served as the Associate Director of Statistical Science at RenSci (Beijing) Pharmaceutical Technology Co., Ltd. from September 2016 to September 2018. Kezhen also had a brief stint at AstraZeneca as a Statistician-Manager in 2016.
Kezhen's earlier work experience includes roles at Biogen, where they worked as a Sr. Biostatistician from February 2016 to April 2016, and as a Biostatistician from January 2014 to January 2016. Kezhen also interned at Boehringer Ingelheim as a Summer Intern in Biostatistics in 2013.
Prior to that, Kezhen had a co-op position at Janssen, Pharmaceutical Companies of Johnson and Johnson, where they worked in the Biostatistics department from September 2012 to May 2013. Kezhen also interned at Janssen in the same department from May 2012 to August 2012.
In 2011, Kezhen had a Student Summer Internship at Pfizer. Kezhen also worked as a Research Consultant at Yale School of Public Health from September 2009 to August 2010.
Kezhen Liu completed their high school education at Zhoushan High School from 2001 to 2004. They then pursued a Bachelor of Science (B.S.) degree in Biotechnology at Peking University from 2004 to 2008. Following that, Kezhen Liu attended Rutgers University from 2008 to 2013, where they obtained a Ph.D. in Statistics.
September, 2021 - present